Study of Antidepressants in Parkinson's Disease

Completed · Phase 3 · Has a placebo group

Conditions studied: Parkinson Disease, Depression

In brief

The purpose of this study is to find out if two antidepressant medications, paroxetine and venlafaxine, can help control depression in Parkinson's disease, and if these medications affect the motor symptoms of Parkinson's disease such as tremor, stiffness, slowness, and balance.

Key facts

Study ID
NCT00086190
Run by
University of Rochester
People needed
115
Starts
2005-06-01
Expected to finish
2009-11-01
Last updated by the study team
2013-01-04

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.